Russian-European research on HIV, tuberculosis and hepatitis C
The burdens of HIV/AIDS, tuberculosis (TB) and hepatitis C (HCV) represent a major public health challenge for Russia and the wider European region. Global health goals to end HIV and reduce TB deaths and HCV cases by 90 % by 2030 hinge on efforts aimed to optimise innovation in diagnostics and treatment. The EU-funded REACH project will build capacity for improved coordination and integration between European and Russian research centres. Specifically, it will focus on pregnant women, children and adolescents who are considered priority populations in the fight against HIV, TB and HCV. The project aims to better understand the epidemiology, disease progression, treatment and consequences of all three.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeRIA - Research and Innovation action
NW1 2PG London